ArticleNature medicine2024
A federated learning system for precision oncology in Europe: DigiONE.
Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- AI assistance in tumor multidisciplinary teams.ESMO real world data and digital oncology · 2026Review
- Discovery of predictive biomarkers for cancer therapy through computational approaches.Nature reviews. Clinical oncology · 2026Review
- 'Crossing borders' in data standardisation: application of OMOP CDM in an international clinical trial network in precision cancer medicine.Acta oncologica (Stockholm, Sweden) · 2026Article
- Machine learning in cancer imaging for enhanced precision in diagnosis and therapy.Discover computing · 2026Review
- Accelerating precision oncology by converging pragmatic trials and real-world evidence.Nature reviews. Drug discovery · 2025Article
- Precision cancer medicine 2025: some concerns.Acta oncologica (Stockholm, Sweden) · 2025Article
- Association between neoadjuvant paclitaxel dose intensity and outcomes in early triple-negative and HER2-positive breast cancer: a real-world data analysis.ESMO real world data and digital oncology · 2025Article
- Establishing standards: harmonising coding principles for a minimal cancer dataset in the OMOP Common Data Model.ESMO real world data and digital oncology · 2025Article
- Advancing real-world research in thoracic malignancies: learnings from the international I-O Optimise initiative.Future oncology (London, England) · 2025Review
- Advancing Medical Imaging Research Through Standardization: The Path to Rapid Development, Rigorous Validation, and Robust Reproducibility.Investigative radiology · 2025Review
- Multimodal deep learning approaches for precision oncology: a comprehensive review.Briefings in bioinformatics · 2024Review
- Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer Centers.Applied clinical informatics · 2024Article
- Clinical bioinformatics desiderata for molecular tumor boards.Briefings in bioinformatics · 2024Review
- DIGICORE, an international research consortium, is building infrastructure and skills to transform digital oncology research across Europe.ESMO real world data and digital oncology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
38195748What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.